Graphite Bio Stock Price To Earning
| GRPHDelisted Stock | USD 2.67 0.05 1.84% |
Graphite Bio fundamentals help investors to digest information that contributes to Graphite Bio's financial success or failures. It also enables traders to predict the movement of Graphite Stock. The fundamental analysis module provides a way to measure Graphite Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Graphite Bio stock.
Graphite |
Graphite Bio Company Price To Earning Analysis
Graphite Bio's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Graphite Bio Price To Earning | 0.70 X |
Most of Graphite Bio's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Graphite Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Graphite Bio has a Price To Earning of 0.7 times. This is 97.29% lower than that of the Biotechnology sector and 85.8% lower than that of the Health Care industry. The price to earning for all United States stocks is 97.56% higher than that of the company.
Graphite Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Graphite Bio's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Graphite Bio could also be used in its relative valuation, which is a method of valuing Graphite Bio by comparing valuation metrics of similar companies.Graphite Bio is currently under evaluation in price to earning category among its peers.
Graphite Fundamentals
| Return On Equity | -0.52 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | 1.88 M | |||
| Shares Outstanding | 58.24 M | |||
| Shares Owned By Insiders | 9.17 % | |||
| Shares Owned By Institutions | 84.40 % | |||
| Number Of Shares Shorted | 704.04 K | |||
| Price To Earning | 0.70 X | |||
| Price To Book | 1.01 X | |||
| EBITDA | (70.7 M) | |||
| Net Income | (124.65 M) | |||
| Cash And Equivalents | 322.29 M | |||
| Cash Per Share | 5.54 X | |||
| Total Debt | 362 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 27.07 X | |||
| Book Value Per Share | 3.17 X | |||
| Cash Flow From Operations | (90.01 M) | |||
| Short Ratio | 7.93 X | |||
| Earnings Per Share | (2.19) X | |||
| Price To Earnings To Growth | (0.08) X | |||
| Target Price | 7.0 | |||
| Beta | 0.2 | |||
| Market Capitalization | 189.84 M | |||
| Total Asset | 188.46 M | |||
| Retained Earnings | (367.05 M) | |||
| Working Capital | 183.22 M | |||
| Current Asset | 8 K | |||
| Current Liabilities | 451 K | |||
| Annual Yield | 0.30 % | |||
| Net Asset | 188.46 M |
About Graphite Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Graphite Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Graphite Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Graphite Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Graphite Stock
If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |